Intervention not reported
MMRV vs MMR ‐ by brand ‐ from 0 to 42 days after vaccination (Priorix‐Tetra) · children 9 months to 15 years old
The intervention showed no clear difference in MMRV vs MMR ‐ by brand ‐ from 0 to 42 days after vaccination… (low certainty).
1 finding from 1 review
Intervention not reported
MMRV vs MMR ‐ by brand ‐ from 7 to 10 days after vaccination (Priorix‐Tetra) · children 9 months to 15 years old
The intervention may leads to higher MMRV vs MMR ‐ by brand ‐ from 7 to 10 days after vaccination… (low certainty).
1 finding from 1 review
Intervention not reported
MMRV vs MMR ‐ by brand ‐ from 0 to 42 days after vaccination (ProQuad) · children 9 months to 15 years old
The intervention may leads to higher MMRV vs MMR ‐ by brand ‐ from 0 to 42 days after vaccination (ProQuad) (low certainty).
1 finding from 1 review
Intervention not reported
MMRV vs MMR ‐ by brand ‐ from 7 to 10 days after vaccination (ProQuad) · children 9 months to 15 years old
The intervention may leads to higher MMRV vs MMR ‐ by brand ‐ from 7 to 10 days after vaccination (ProQuad) (low certainty).
1 finding from 1 review
Intervention not reported
Proportion of births for which Hepatitis B birth dose vaccination was provided within 30 days · Health Care Workers (HCWs), Village Health Volunteers (VHVs), newborn children
1 finding from 1 review
no estimate extracted
1525 participants
Very low
Intervention not reported
Proportion of births where Hepatitis B birth dose vaccination was administered within 0‐1 day · Health Care Workers (HCWs), Village Health Volunteers (VHVs), newborn children
1 finding from 1 review
no estimate extracted
1525 participants
Very low
Intervention not reported
Proportion of births where Hepatitis B birth dose vaccination was administered within 2‐7 days · Health Care Workers (HCWs), Village Health Volunteers (VHVs), newborn children
1 finding from 1 review
no estimate extracted
1525 participants
Very low
Service utilisation – attendance antenatal care appointments (attendance for antenatal influenza vaccination) · pregnant and postpartum women
Digital targeted client communication via mobile devices showed no clear difference in service utilisation – attendance antenatal care appointments… compared with digital non‐targeted client communication (pregnant and postpartum… (low certainty).
1 finding from 1 review
Service utilisation – attendance for necessary healthcare (attendance for vaccinations at 6–12 months, attendance at HIV medical appointments) · parents of children aged < 5 years
Digital targeted client communication via mobile devices may leads to higher service utilisation – attendance for necessary healthcare… compared with standard care or no intervention (parents of children aged under… (low certainty).
1 finding from 1 review
Service utilisation – attendance for necessary healthcare (attendance for vaccinations at 14 weeks) · parents of children aged < 5 years
Digital targeted client communication via mobile devices showed no clear difference in service utilisation – attendance for necessary healthcare… compared with non‐digital targeted client communication (parents of children aged… (low certainty).
1 finding from 1 review
Service utilisation – attendance for necessary healthcare – attendance for vaccinations at 6 months · parents of children aged < 5 years
Digital targeted client communication via mobile devices showed no clear difference in service utilisation – attendance for necessary healthcare –… compared with digital non‐targeted client communication (parents of children aged… (low certainty).
1 finding from 1 review
Health service utilization ‐ attendance for: breast cancer screening, cervical screening, voluntary medical male circumcision, HPV or HBV vaccination · Adults (age over 24 years)
Digital targeted client communication via mobile devices showed no clear difference in health service utilization ‐ attendance for: breast cancer… compared with non‐digital, targeted communication (low certainty).
1 finding from 1 review
Vaccination coverage · infants
1 finding from 1 review
Vaccination coverage · preventing poliomyelitis
1 finding from 1 review
Vaccination coverage · infants
IPV‐OPV showed no clear difference in vaccination coverage ( compared with OPV (low certainty).
1 finding from 1 review
RR 1.01 [0.96, 1.06]
1 participants
Low
Asthma exacerbation (adverse effects) caused by inactivated influenza vaccine, measured in the first 2 weeks following vaccination ‐ children (over 3 years of age) given inactivated influenza vaccine · people with asthma
1 finding from 1 review
Asthma exacerbation (adverse effects) caused by inactivated influenza vaccine, measured in the first 2 weeks following vaccination ‐ adults given inactivated influenza vaccine · people with asthma
1 finding from 1 review
Intervention not reported
How many people get cholera during the first 2 years after vaccination? · Adults and children
1 finding from 1 review
Uptake of HPV vaccineb · Adolescents (10-19 years)
1 finding from 1 review
Intervention not reported
Cervical cancer ‐ not measured · adolescent girls and women aged 15 to 26 years who are hrHPV negative before vaccination
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found